The CC-chemokine RANTES increases the attachment of human immunodeficiency virus type 1 to target cells via glycosaminoglycans and also activates a signal transduction pathway that enhances viral infectivity

Journal of Virology

Volumn 73, Issue 8, 1999, Pages 6370-6379

  Trkola, Alexandra ^a   Gordon, Cynthia ^a,b   Matthews, Jamie ^a   Maxwell, Elizabeth ^a   Ketas, Tom ^a   Czaplewski, Lloyd ^c   Proudfoot, Amanda E I ^d   Moore, John P ^a,e  

^a AARON DIAMOND AIDS RESEARCH CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c British Biotech Pharmaceuticals Ltd   (United Kingdom)

^d SERONO PHARMACEUTICAL RES INSTITUTE   (Switzerland)

^e ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; GLYCOSAMINOGLYCAN; HERBIMYCIN A; RANTES;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL INTERACTION; CELL SURFACE; CHO CELL; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TARGET CELL; VIRION; VIRUS ADSORPTION; VIRUS INFECTIVITY; VIRUS MUTANT;

EID: 0032768967     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.8.6370-6379.1999     Document Type: Article

References (96)

1. Alkhatib, G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Berger. 1996. CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropie HIV-I. Science 272: 1955-1958.
2. Amara, A., S. Le Gall, O. Schwartz, J. Salamero, M. Montes, P. Loetscher, M. Baggiolini, J.-L. Virelizier, and F. Arenzana-Seisdedos. 1997. HIV coteceptor downregulation as antiviral principle: SDF-1α-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J. Exp. Med. 186:139-146.
3. Amzazi, S., Y. L. Ylisastigul, Y. Bakri, L. Rabehi, L. Gattegno, M. Parmentier, J. C. Gluckman, and A. Benjouad. 1998. The inhibitory effect of RANTES on the infection of primary macrophages by R5 human immunodeficiency virus type-1 depends on the macrophage activation state. Virology 252:96-105.
4. Aramori, I, S. S. G. Ferguson. P. D. Bieniasz, B. R. Cullen, and M. G. Caron. 1997. Molecular mechanism of desensitization of the chemokine receptor CCR-5: receptor signalling and internalization are dissociable from its role as an HIV-I co-receptor. EMBO J. 16:4606-4616.
5. Arenzana-Seisedos, F., J.-L. Virelizier, D. Rousset, I. Clark-Lewis, P. Loetscher, B. Moser, and M. Baggiolini. 1996. HIV blocked by chemokine antagonist. Nature 383:400.
6. Bacon, K. B., B. A. Premack, P. Gardner, and T. J. Schall. 1995. Activation of dual T cell signaling pathways by the chemokine RANTES. Science 269:1727-1730.
7. Bacon, K. B., T. J. Schall, and D. J. Dairaghi. 1998. RANTES activation of phospholipase D in Jurkat T cells: Requirement of GTP-binding proteins ARF and RhoA J. Immunol. 160:1894-1900.
8. Berger, E. A. 1997. HIV entry and tropism: the chemokine receptor connection. AIDS II(Suppl. A):S3-S16.
9. Bess, J. W., R. J. Gorelick, L. E. Henderson, and L. O. Arthur. 1997. Microvesicles are a source of contaminating cellular proteins found in purified HIV-I preparations. Virology 230:134-144.
10. 2+ signaling. J. Exp. Med 188:1917-1927.
11. Cantin, R., J.-F. Fortin, G. Lamontagne, and M. Tremblay. 1997. The presence of host-derived HLA-DRI on human immunodeficiency virus type 1 increases viral infectivity. J. Virol. 17:1922-1930.
12. Capobianchi, M. R., I. Abbate, G. Antonelli, O. Turriziani, A. Dolei, and F. Dianzani. 1998. Inhibition of HIV type 1 BaL replication by MIP-1α, MIP-1β, and RANTES in macrophages. AIDS Res. Hum. Retroviruses 14:233-240.
13. Carey, D. 1997. Syndecans: multifunctional cell-surface coreceptors. Biochem. J. 327:1-16.
14. Cerami, C., U. Frevert, P. Sinnis, B. Takacs, and V. Nussenzweig. 1994. Rapid clearance of malaria circumsporozoite protein (CS) by hepatocytes. J. Exp. Med. 179:695-701.
15. Chen, B. K., K. Saksela, R. Andino, and D. Baltimore. 1994. Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by super-infection of nonproductively infected cell lines with recombinant luciferase-encoding viruses. J. Virol. 68:654-660.
16. Chen, Y., T. Maguire, R. Hileman, J. Fromm, J. Esko, R. Linhardt, and R. Marks. 1997. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med. 3:866-871.
17. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P. D. Ponath, L. Wu, C. R. Mackay, G. LaRosa, W. Newman, N. Gerard, G. Gerard, and J. Sodroski. 1996. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-I isolates. Cell 85:1135-1148.
18. Chuck, A. S., and B. O. Palsson. 1996. Consistent and high rates of gene transfer can be obtained using flow-through transduction over a wide range of retroviral titers. Hum. Gene Ther. 7:743-750.
19. Chung, C.-S., J.-C. Hsiao, Y.-S. Chang, and W. Chang. 1998. A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate. J. Virol. 72:1577-1585.
20. Chung, C. W., R. M. Cooke, A. E. Proudfoot, and T. N. C. Wells. 1995. The three-dimensional solution structure of RANTES. Biochemistry 34:9307-9314.
21. Clore, G. M., E. Appella, M. Yamada, K. Matsushima, and A. M. Gronenborn. 1990. Three-dimensional structure of interleukin 8 in solution. Biochemistry 29:1689-1696.
22. Cocchi, F., A. L. DeVico, A. Garzino-Demo, S. K. Arya, R. C. Gallo, and P. Lusso. 1995. Identification of RANTES, MIP-1 alpha and MIP-1 beta as the major HIV suppressive factors produced by CD8+ T cells. Science 270: 1811-1815.
23. Connor, R. I., K. E. Sheridan, D. Ceradini, S. Choe, and N. R. Landau. 1997. Change in coreceptor use correlates with disease progression in HIV-I infected individuals. J. Exp. Med. 185:621-628.
24. Czaplewski, L. G., J. McKeating, C. J. Craven, L. D. Higgins, V. Appay, A. Brown, T. Dudgeon, L. A. Howard, T. Meyers, J. Owen, S. R. Palan, P. Tan, G. Wilson, N. R. Woods, C. M. Heyworth, B. I. Lord, D. Brotherton, R. Christison, S. Craig, S. Cribbes, R. M. Edwards, S. J. Evans, R. Gilbert, P. Morgan, E. Randle, N. Schofeid, P. G. Varley, J. P. Waltho, and M. G. Hunter. Identification of amino acid residues critical for aggregation of human CC chemokines MIP-1α, MIP-1β and RANTES: characteristics of active disaggregated chemokine variants. J. Biol. Chem., in press.
25. Dairaghi, D. J., K. S. Soo, E. R. Oldham, B. A. Premack, T. Kitamura, K. B. Bacon, and T. J. Schall. 1998. RANTES-induced T cell activation correlates with CD3 expression. J. Immunol. 160:426-433.
26. Dolei, A., A. Biolchini, C. Serra, S. Currali, E. Gomes, and F. Dianzani. 1998. Increased replication of a T-cell-tropic HIV strain and CXC chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1α, MIP-1β and RANTES β-chemokines. AIDS 12:183-190.
27. Doms, R. W., and S. C. Peiper. 1997. Unwelcome guests with master keys: how HIV uses chemokine receptors for cellular entry. Virology 235:179-190.
28. Doranz, B. J., J. Rucker, V. Yi, R. J. Smyth, M. Samson, S. Peiper, M. Parmentier, R. G. Collman, and R. W. Doms. 1996. A dual-tropic, primary HIV-I isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-2b as fusion cofactors. Cell 85:1149-1159.
29. Dragic, T., V. Litwin, G. P. Allaway, S. R. Martin, Y. Huang, K. A. Nagashima, C. Cayanan, P. J. Maddon, R. A. Koup, J. P. Moore, and W. A. Paxton. 1996. HIV-I entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-673.
30. Esko, J. D. 1989. Replica plating of animal cells. Methods Cell Biol. 32:387-422.
31. Esko, J. D., T. E. Stewart, and W. H. Taylor. 1985. Animal cell mutants defective in glycosaminoglycan biosynthesis. Proc. Natl. Acad. Sci. USA 82:3197-3201.
32. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-I entry cofactor: functional cDNA cloning of a seven-transmembrane G protein-coupled receptor. Science 272:872-877.
33. Fortin, J.-F., R. Cantin, G. Lamontagne, and M. Tremblay. 1997. Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity. J. Virol. 71:3588-3596.
34. Gantt, S. M., P. Claviyo, X. Bal, J. D. Esko, and P. Sinnis. 1997. Cell adhesion to a motif shared by the malaria circumsporozoite protein and thrombospondin is mediated by its glycosaminoglycan-binding region and not by CSVTCG. J. Biol. Chem. 272:19205-19213.
35. Gluschankof, P., I. Mondor, H. R. Gelderblom, and Q. J. Sattentau. 1997. Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type 1 (HIV-I) preparations. Virology 230:125-133.
36. Gordon, C. J., M. A. Muesing, A. E. I. Proudfoot, C. A. Power, J. P. Moore, and A. Trkola. 1999. Enhancement of human immunodeficiency virus type 1 infection by the CC-chemokine RANTES is independent of the mechanism of virus-cell fusion. J. Virol. 73:684-694.
37. Hoogewerf, A. J., G. S. Kuschert, A. E. Proudfoot, F. Borlat, I. Clark-Lewis, C. A. Power, and T. N. Wells. 1997. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 36:13570-13578.
38. Ilangumaran, S., A. Briol, and D. Hoessli, 1998. CD44 selectively associates with active src family tyrosine kinases lck and fyn in glycosphongollipid rich plasma membrane domains of human peripheral blood lymphocytes. Blood 91:3901-3908.
39. Ito, M., M. Baba, A. Sato, R. Pauwels, E. De Clerq, and S. Shigeta. 1987. Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro. Antiviral Res. 7:361-367.
40. Jackson, T., F. Ellard, R. Ghazaleh, S. Brookes, W. Blakemore, A. Corteyn, D. Stuart, J. Newman, and A. King. 1996. Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J. Virol. 70:5282-5287.
41. Kadan, M. J., S. Sturm, W. F. Anderson, and M. A. Eglitis. 1992. Detection of receptor-specific murine leukemia virus binding to cells by immunofluorescence analysis. J. Virol. 66:2281-2287.
42. Kakkanaiah, V. N., E. A. Ojo-Amaize, and J. B. Peter. 1998. Concentrations of circulating beta-chemokines do not correlate with viral load in human immunodeficiency virus-infected individuals. Clin. Diagn. Lab. Immunol. 5:499-502.
43. Karpus, W. J., N. W. Lukacs, K. J. Kennedy, W. S. Smith, S. D. Hurst, and T. A. Barrett. 1997. Differential CC chemokine-induced enhancement of T helper cell cytokine production. J. Immunol. 158:4129-4136.
44. Kelly, M. D., H. M. Naif, S. L. Adams, A. L. Cunningham, and A. R. Lloyd. 1998. Dichotomous effects of β-chemokines on HIV replication in monocytes and monocyte-derived macrophages. J. Immunol. 160:3091-3095.
45. Kinter, A., A. Catanzaro, J. A. Monaco, M. Ruiz, J. Justement, S. Moir, J. Arthos, A. Oliva, L. Ehler, S. Mizell, R. Jackson, M. Ostrowski, J. Hoxie, R. Offord, and A. S. Fauci. 1998. CC-chemokines enhance the replication of T tropic strains of HIV-I in CD4+ T cells: role of signal transduction. Proc. Natl. Acad. Sci. USA 95:11880-11885.
46. Klimstra, W., K. Ryman, and R. Johnston. 1998. Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J. Virol. 72:7357-7366.
47. Kozak, S. L., E. J. Platt, N. Madani, F. E. Ferro, Jr., K. Peden, and D. Kabat. 1997. CD4, CXCR-4, and CCR-5 dependencies for infection by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1. J. Virol. 71:873-882.
48. Krowka, J. F., M. L. Gesner, M. S. Ascher, and H. W. Sheppard. 1997. Lack of associations of chemotactic cytokines with viral burden, disease progression, or lymphocyte subsets in HIV-infected individuals. Clin. Immunol. Immunopathol. 85:21-27.
49. Lidholt, K., J. L. Weinke, C. S. Kiser. F. N. Lugemwa, K. J. Bame. S. Cheifetz, J. Massague, U. Lindahl, and J. D. Esko. 1992. A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis. Proc. Natl. Acad. Sci. USA 89:2267-2271.
50. Lubkowski, J., G. Bujacz, L. Boque, P. J. Domaille, T. M. Handel, and A. Wlodawer. 1997. The structure of MCP-1 in two crystal forms provides a rare example of variable quaternary interactions. Nat. Struct. Biol. 4:64-69.
51. Mack, M., B. Luckow, P. J. Nelson, J. Lihak, G. Simmons, P. R. Clapham, N. Signoret, M. Marsh, M. Stangassinger, F. Borlat, T. N. C. Wells, D. Schlöndorff, and A. E. I. Proudfoot. 1998. Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity. J. Exp. Med. 187:1215-1224.
52. McKenzie, S. W., G. Dallalio, M. North, P. Frame, and R. T. Means. 1996. Serum chemokine levels in patients with non-progressing HIV infection. AIDS 10:F29-F33.
53. Miller, D. G., and A. D. Miller. 1994. A family of retroviruses that utilize related phosphate transporters for cell entry. J. Virol. 68:8270-8276.
54. Mondor, I., S. Ugolini, and Q. J. Sattentau. 1998. Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans. J. Virol. 72:3623-3634.
55. Montgomery, R. I., M. S. Warner, R. J. Lum, and P. G. Spear. 1996. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87:427-436.
56. Moore, J. P., A. Trkola, and T. Dragic. 1997. Co-receptors for HlV-I entry. Curr. Opin. Immunol. 9:551-562.
57. Morgan, J. R., J. M. LeDoux, R. G. Snow, R. G. Tompkins, and M. L. Yarmush. 1995. Retrovirus infection: effect of time and target cell number. J. Virol. 69:6994-7000.
58. Moriuchi, H., M. Moriuchi, and A. S. Fauci. 1998. Factors secreted by human T lymphotropic virus type 1 (HTLV-I)-infected cells can enhance or inhibit replication of HIV-I in HTLV-I-uninfected cells: implications for in vivo coinfection with HTLV-I and HIV-I. J. Exp. Med. 187:1689-1697.
59. Moriuchi, M., H. Moriuchi, C. Combadiere, P. M. Murphy, and A. S. Fauci. 1996. CD8+ T cell-derived factor(s), but not β-chemokines RANTES, MIP-1α, and MIP-1β suppress HIV-I replication in monocyte/macrophages. Proc. Natl. Acad. Sci. USA 93:15341-15345.
60. Muller, P., M. Engelstadter, A. Werner, J. Braner, S. Staszewski, V. Miller, H. W, Doerr, R. Kurth, and K. Cichutek. 1997. Increased serum and mRNA levels of RANTES associated with elevated levels of activated CD8+CD38+ T cells in HIV-I infected individuals. Intervirology 40:263-270.
61. Nussbaum, O., C. C. Broder, and E. A. Berger. 1994. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation. J. Virol. 68:5411-5422.
62. Ohshiro, Y., T. Murakami, K. Matsuda, K. Nishioka, K. Yoshida, and N. Yamamoto. 1996. Role of cell surface glycosaminoglycans of human T cells in human immunodeficiency virus type-1 (HIV-I) infection. J. Virol. 40:827-835.
63. Okada, T., and M. Gurney. 1995. Single basic amino acid substitutions at position 302 or 320 in the V3 domain of HIV type 1 are not sufficient to alter the antiviral activity of dextran sulfate and heparin. AIDS Res. Hum. Retroviruses 11:571-575.
64. Oravecz, T., M. Pall, and M. A. Norcross. 1996. β-Chemokine inhibition of monocytotropic HIV-I infection. Interference with a postbinding fusion step. J. Immunol. 157:1329-1332.
65. Oravecz, T., M. Pall, G. Roderiquez, M. D. Gorrell, M. Ditto, N. Y. Nguyen, R. Boykins, E. Unsworth, and M. A. Norcross. 1997. Regulation of the receptor specificity and function of the chemokine RANTES (Regulated on Activation, Normal T cell Expressed and Secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J. Exp. Med. 186:1865-1872.
66. Oravecz, T., M. Pall, J. Wang, G. Roderiquez, M. Ditto, and M. A. Norcross. 1997. Regulation of anti-HIV-I activity of RANTES by heparan sulfate proteoglycans. J. Immunol. 159:4587-4592.
67. Orentas, R. J., and J. E. K. Hildreth. 1993. Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV. AIDS Res. Hum. Retroviruses 9:1157-1165.
68. Orloff, G. M., S. L. Orloff, M. S. Kennedy, P. J. Maddon, and J. S. McDougal. 1991. Penetration of CD4 T cells by HIV-I. The CD4 receptor does not internalize with HIV, and CD4-related signal transduction events are not required for entry. J. Immunol. 146:2578-2587.
69. Ott, V., and A. Rapraeger. 1998. Tyrosine phosphorylation of syndecan-1 and -4 cytoplasmic domains in adherent B82 fibroblasts. J. Biol. Chem. 273: 35291-35298.
70. Paavola, C. D., S. Hemmerich, D. Grunberger, I. Polsky, A. Bloom, R. Freedman, M. Mulkins, S. Bhakta, D. McCarley, L. Wiesent, B. Wong, K. Jarnagin, and T. M. Handel. 1998. Monomeric monocyte chemoattractant protein-1 (MCP-I) binds and activates the MCP-I receptor CCR2B. J. Biol. Chem. 273:33157-33165.
71. Patel, M., M. Yanagishita, G. Rodriquez, D. C. Bou-Habib, T. Oravecz, V. C. Hascall, and M. A. Norcross. 1993. Cell surface heparan sulfate proteoglycan mediates HIV-I infection of T cell lines. AIDS Res. Hum. Retroviruses 9:167-174.
72. Poret, C. D., K. V. Lukacs, G. Box, Y. Takeuchi, and M. K. L. Collins. 1998 Cationic liposomes enhance the rate of transduction by a recombinant retroviral vector in vitro and in vivo. J. Virol. 72:4832-4840.
73. Premack, B. A., and T. J. Schall. 1996. Chemokine receptors: gateways to inflammation and infection. Nat. Med. 2:1174-1178.
74. Proost, P., I. De Meester, D. Schols, S. Struyf, A.-M. Lambeir, A. Wuyts, G. Oppendakker, E. De Clercq, S. Scharpe, and J. van Damme. 1998. Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-I-infection. J. Biol. Chem. 273:7222-7227.
75. Proudfoot, A. E., C. A. Power, A. Hoogewerf, M. O. Montjovent, F. Borlat, and T. N. C. Wells. 1995. Characterisation of the RANTES/MIP-1 alpha receptor (CC CKR-1) stably transfected in HEK 293 cells and the recombinant ligands. FEBS Lett. 376:19-23.
76. Rizzuto, C. D., and J. G. Sodroski. 1997. Contribution of virion ICAM-1 to human immunodeficiency virus infectivity and sensitivity to neutralization. J. Virol. 71:4847-4851.
77. Roderiquez, G., T. Oravecz, M. Yanagishita, D. C. Bou-Habib, H. Mostowski, and M. A. Norcross. 1995. Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41. J. Virol. 69:2233-2239.
78. Schmidtmayerova, H., B. Sherry, and M. Bukrinsky. 1996. Chemokines and HIV replication. Nature 382:767.
79. Secchiero, P., D. Sun, A. DeVico, R. Crowley, M. Reitz, Jr., G. Zauli, P. Lusso, and R. Gallo. 1997. Role of the extracellular domain of human herpesvirus 7 glycoprotein B in virus binding to cell surface heparan sulfate proteoglycans. J. Virol. 71:4571-4580.
80. Simmons, G., P. R. Clapham, C. Picard, R. E. Offord, M. M. Rosenkilde, T. W. Schwartz, R. Buser, T. N. C. Wells, and A. E. I. Proudfoot. 1997. Potent inhibition of HIV-I infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science 276:276-279.
81. Sinnis, P., T. E. Willnow, M. R. Briones, J. Herz, and V. Nussenzweig. 1996. Remnant lipoproteins inhibit malaria sporozoite invasion of hepatocytes. J. Exp. Med. 184:945-954.
82. Taub, D. D., S. M. Turcovski-Corrales, M. L. Key, D. L. Longo, and W. J. Murphy. 1996. Chemokines and T lymphocyte activation. J. Immunol. 156: 2095-2103.
83. Trkola, A., and A. Garcia-Sastre. Unpublished results.
84. Trkola, A., T. Dragic, J. Arthos, J. M. Binley, W. C. Olson, G. P. Allaway, C. Cheng-Mayer, J. Robinson, P. J. Maddon, and J. P. Moore. 1996. CD4 dependent, antibody sensitive interactions between HIV-I and its co-receptor CCR5. Nature 384:184-186.
85. Trkola, A., W. A. Paxton, S. P. Monard, J. A. Hoxie, M. A. Siani, D. A. Thompson, L. Wu, C. R. Mackay, R. Horuk, and J. P. Moore. 1998. Genetic subtype independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines. J. Virol. 72:396-404.
86. Trybala, E., T. Bergstrom, D. Spillman, B. Svennerholm, S. Olofsson, S. Flynn, and P. Ryan. 1996. Mode of interaction between pseudorabies virus and heparan sulfate/heparin. Virology 218:35-42.
87. Turner, L., S. G. Ward, and J. Westwick. 1995. RANTES-activated human T lymphocytes. J. Immunol. 155:2437-2444.
88. Ugolini, S., I. Mondor, P. W. H. I. Parren, D. R. Burton, S. Tilley, P. J. Klasse, and Q. J. Sattentau. 1997. Inhibition of virus attachment to CD4+ target cells is a major mechanism of T cell line-adapted HIV-I neutralization. J. Exp. Med. 186:1287-1298.
89. Wagner, L., O. O. Yang, E. A. Garcia-Zepeda, Y. Ge, S. A. Kalams, B. D. Walker, M. S. Pasternak, and A. D. Luster. 1998. β-Chemokines are released from HIV-I specific cytotoxic T-cell granules complexed to proteoglycans. Nature 391:908-911.
90. Wang, H., R. Paul, R. E. Burgeson, D. R. Keene, and D. Kabat. 1991. Plasma membrane receptors for ecotropic murine retroviruses require a limiting accessory factor. J. Virol. 65:6468-6477.
91. Ward, S. G., K. Bacon, and J. Westwick. 1998. Chemokines and T lymphocytes: more than an attraction. Immunity 9:1-11.
92. Wells, T. N. C., C. A. Power, M. Lusti-Narasimhan, A. J. Hoogewerf, R. M. Cooke, C.-W. Chung, M. C. Peitsch, and A. E. I. Proudfoot. 1996. Selectivity and antagonism of chemokine receptors. J. Leukoc. Biol. 59:53-60.
93. Wong, M., and E. N. Fish. 1998. RANTES and MIP-1α activate STATS in T cells. J. Biol. Chem. 273:309-314.
94. Wu, L., N. P. Gerard, R. Wyatt, H. Choe, C. Parolin, N. Ruffing, A. Borsetti, A. A. Cardoso, E. Desjardin, W. Newman, C. Gerard, and J. Sodroski. 1996. CD4-induced interaction of primary HIV-I gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384:179-183.
95. WuDunn, D., and P. G. Spear. 1989. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 63:52-58.
96. Ylisastigui, L., J. Vizzavona, E. Drakopoulou, P. Paindavoine, C.-F. Calvo, M. Parmentier, J. C. Gluckman, C Vita, and A. Benjouad. 1998. Synthetic full-length and truncated RANTES inhibit HIV-I infection of primary macrophages. AIDS 12:977-984.